SNOA
NASD Sonoma Pharmaceuticals, Inc.$1.15 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.15, $0.06 below the day’s high of $1.21
- YTD change
- -68.41%
- vs 20-day SMA
- -7.09%
- vs 200-day SMA
- -37.91%
Price ranges
Price & Performance
-1.09 (-48.66%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.9% away from all-time highs of $1,484.59
- SNOA is down 68% since the beginning of the year
- SNOA is down 71% over the past 12 months
- SNOA is down 7% over the past 1 month
- 3% of all SNOA investors are betting against SNOA
SNOA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -71.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -5.74%
- vs 8-day SMA
- -4.47%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Sonoma Pharmaceuticals, Inc. is a global healthcare leader in the development and production of stabilized hypochlorous acid (HOCl) products. Its products are used for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions, podiatry, animal health care, and non-toxic disinfectants. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Boulder, CO.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.